BRAF: a driver of the serrated pathway in colon cancer. Rustgi AK (2013) Cancer Cell 24: 1-2 Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, Gruber SB (2011) Cancer Epidemiol Biomarkers Prev 20: 522-9 Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas. Ceha HM, Clement MJ, Polak MM, Offerhaus GJ, Slebos RJ (1998) Pancreas 17: 85-8 Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Ye C, Shrubsole MJ, Cai Q, Ness R, Grady WM, Smalley W, Cai H, Washington K, Zheng W (2006) Oncol Rep 16: 429-35 Returning individual research results: development of a cancer genetics education and risk communication protocol. Roberts JS, Shalowitz DI, Christensen KD, Everett JN, Kim SY, Raskin L, Gruber SB (2010) J Empir Res Hum Res Ethics 5: 17-30
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.